Flipside Finance
AZ

AstraZeneca PLC

AZNEquity
$191.29-0.37%
24h Volume: $0.00B

AI Summary

Updated 4h ago

AstraZeneca PLC (AZN) has lost significant upward energy

AstraZeneca PLC (AZN) has lost significant upward energy. Momentum indicators are at historically low levels across multiple timeframes — sellers have had the upper hand recently. Price is approaching resistance at $182 -- $216, 3% above current levels. For reference: Flow Score 32/100, Trend & Momentum Score 46/100.

36NEUTRAL

Asset Health Metrics

46
Trend & Momentum
32
Money Flow
69
Risk

Technical Analysis

Market Positioning

Where does this asset sit across four dimensions? Extension (how stretched price is vs its own history), Momentum (RSI, MACD, rate of change), Flow (volume and money flow), and Volatility (how quiet or active). Each bar shows a 0–100 percentile compared to the last year of data. Key levels show the nearest demand and supply zones from our confluence analysis.

Extension
[avg: 28th]
28thpercentile
Low
Normal
High
28th percentile
Momentum
[avg: 8th]
8thpercentile
Low
Normal
High
8th percentile
Flow
[avg: 11th]
11thpercentile
Low
Normal
High
11th percentile
Volatility
[avg: 27th]
27thpercentile
Low
Normal
High
27th percentile

Key Levels

Demand: $165–$169 (12.6% below)
score: 1.08
Supply: $182–$216 (2.6% above)
score: 5.40
View full Key Levels section →

Looking at the full picture for AstraZeneca PLC (AZN): extension is below average (28th percentile), momentum is deeply below average — at historically low levels (8th percentile), flow is deeply below average — at historically low levels (11th percentile), volatility is below average (27th percentile). All three directional dimensions — extension, momentum, and flow — are in the lower portion of their historical ranges. The asset is under broad pressure, with price compressed, upward energy depleted, and selling pressure elevated. There is no positive divergence to point to. Watch whether extension drops further toward the support zone at $59 -- $74 (65% below). A combination of low extension and low momentum at a structural support level would be a more significant confluence.

Conclusion

AstraZeneca PLC (AZN) is in a mixed position. Some indicators are above average, others below, but nothing is at an extreme level that defines the current setup strongly in either direction. These readings update daily. Flipside shows what is happening now, grounded in the data — not what will happen next.

Your portfolio. Your context. Smarter decisions.

Connect your holdings and let the Flipside Agent analyze market changes through the lens of your portfolio.

AI + Portfolio

Personalized insights based on your actual holdings

Daily Briefing

Major market movements delivered to your inbox

Watchlists

Track the assets that matter most to you

No credit card required